MDCO: MEDICINES CO Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 12 hrs, 24 mins

Symbol	Value	Change	Percentage Change
DJIA	10,226.94	203.52	2.03%
NASDAQ	2,154.06	41.62	1.97%
S&P 500	1,093.08	23.78	2.22%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

MEDICINES CO

MDCO

Stock price

7.67 0.00 0.00%

as of 04:00 PM EST on 11/09/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

7.6635 -0.0065 -0.08%

as of 04:11 PM EST on 11/09/09

Analyst Consensus

Hold
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: MDCO

MEDICINES CO Real-Time Headlines

Customize
Monday, November 09, 2009

SEC Filing: Quarterly Financials

5:16:00 PM | Thomson Financial

Monday, November 2, 2009

Medicines Co. Misses & Cuts - Analyst Blog

11/2/09 | Zacks Investment Research

Friday, October 30, 2009

Zacks Sell List Highlights: The Great Atlantic & Pacific Tea Co., Encore Wire Corp., Pool Corp. and The Medicines Co. ..

10/30/09 | PR-inside - Austria

Zacks Sell List Highlights: The Great Atlantic & Pacific Tea Co., Encore Wire Corp., Pool Corp. and The Medicines Co.

10/30/09 | Business Wire

Wednesday, October 28, 2009

Medicines Co. Q3 Loss Narrows; Cuts FY09 EPS View - Update

10/28/09 View all Related Articles > | RTTNews

The Medicines Co. lowers FY09 EPS view to 14c-24c from 88c-$1.10

10/28/09 | Theflyonthewall.com

SEC Filing: Current Event

10/28/09 | Thomson Financial

The Medicines Co. reports Q3 EPS 10c vs. consensus of (5c)

10/28/09 | Theflyonthewall.com

The Medicines Company Reports Third Quarter 2009 Financial Results

10/28/09 | Marketwire

Monday, October 26, 2009

The Medicines Company Announces Positive CHMP Opinion For Angiox(R) For Use In Heart Attack Patients Undergoing Emergency Heart Procedures

10/26/09 View all Related Articles > | Medical News Today - UK

Friday, October 23, 2009

The Medicines Company Announces Positive CHMP Opinion for Angiox (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures

10/23/09 View all Related Articles > | PharmaLive

Stock Hot Tips Alert on CCTR,CSRH NRG,J.D. POWER,The Medicines Company

10/23/09 | WallSt.net

Medicines Co. gets positive EU panel result

10/23/09 View all Related Articles > | AP ONLINE

The Medicines Company Announces Positive CHMP Opinion for Angiox® (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures

10/23/09 | Business Wire

Thursday, October 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

10/15/09 View all Related Articles > | PharmaLive

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

10/15/09 | Marketwire

Friday, October 9, 2009

Orbimed Advisors reports passive 5.46% The Medicines Company stake

10/9/09 | Theflyonthewall.com

Thursday, October 8, 2009

Medicines Co. sues generic rivals over Angiomax

10/8/09 View all Related Articles > | AP ONLINE

The Medicines receives new patent for Angiomax

10/8/09 | Theflyonthewall.com

The Medicines Company Announces Second New Patent Issuance for Angiomax(R)

10/8/09 | Marketwire

Tuesday, October 6, 2009

Medicines sets 3Q revenue outlook below forecasts

10/6/09 | AP ONLINE

The Medicines Co (MDCO) Guides Q3 Below The Street

10/6/09 | StreetInsider.com

The Medicines Company Announces Preliminary Third Quarter 2009 Top Line Results

10/6/09 View all Related Articles > | PR-inside - Austria

The Medicines Co. sees Q3 total net revenue $96M-$98M vs. consensus of $110M

10/6/09 | Theflyonthewall.com

The Medicines Company Announces Preliminary Third Quarter 2009 Top Line Results

10/6/09 | Marketwire

Monday, October 5, 2009

SEC Filing: Current Event

10/5/09 View all Related Articles > | Thomson Financial

Friday, October 2, 2009

The Medicines Company Announces the Resignation of Its Chief Operating Officer

10/2/09 View all Related Articles > | PharmaLive

Medicines Co. President, COO John Kelley resigns

10/2/09 View all Related Articles > | AP ONLINE

The Medicines Company announces resignation of COO

10/2/09 | Theflyonthewall.com

The Medicines Company Announces the Resignation of Its Chief Operating Officer

10/2/09 | Marketwire

Wednesday, September 30, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

9/30/09 | Marketwire

09/30 - The Medicines Company licenses ready-to-use formulation of ant ...

9/30/09 | Pharmacy Choice

Tuesday, September 29, 2009

The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise

9/29/09 View all Related Articles > | PR-inside - Austria

The Medicines Co. licenses new formulation of Argatroban

9/29/09 | Theflyonthewall.com

The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity

9/29/09 | Marketwire

Monday, September 28, 2009

The Medicines Company Angiomax Reduced Cardiac Mortality By 41%; Reduced Overall Mortality By 25% In Severe Heart Attack Patients Following Angioplasty, Columbia-Presbyterian Medical Center Study

9/28/09 View all Related Articles > | BioSpace

Saturday, September 26, 2009

Boston Scientific Says Data From Horizons-AMI Trial Show Superior Efficacy - Update

9/26/09 View all Related Articles > | RTTNews

Friday, September 25, 2009

The Medicines Co. announces clinical results for HORIZONS-AMI trial

9/25/09 | Theflyonthewall.com

The Medicines Co. announces clinical trial results for

9/25/09 | Theflyonthewall.com

Angiomax Reduced Cardiac Mortality by 41%; Reduced Overall Mortality by 25% in Severe Heart Attack Patients Following Angioplasty

9/25/09 | Marketwire

1 <Next>
Monday, November 09, 2009

SEC Filing: Quarterly Financials

5:16:00 PM | Thomson Financial

Monday, November 2, 2009

Medicines Co. Misses & Cuts - Analyst Blog

11/2/09 | Zacks Investment Research

Wednesday, October 28, 2009

Medicines Co. Q3 Loss Narrows; Cuts FY09 EPS View - Update

10/28/09 | RTTNews

The Medicines Co. lowers FY09 EPS view to 14c-24c from 88c-$1.10

10/28/09 | Theflyonthewall.com

SEC Filing: Current Event

10/28/09 | Thomson Financial

The Medicines Co. reports Q3 EPS 10c vs. consensus of (5c)

10/28/09 | Theflyonthewall.com

Friday, October 23, 2009

European Panel Backs Medicines Co.'s Angiox For Extended Use - Update

10/23/09 View all News Related Articles > | RTTNews

Medicines Co. gets positive EU panel result

10/23/09 | AP ONLINE

Friday, October 9, 2009

Orbimed Advisors reports passive 5.46% The Medicines Company stake

10/9/09 | Theflyonthewall.com

Thursday, October 8, 2009

Medicines Co. sues generic rivals over Angiomax

10/8/09 | AP ONLINE

The Medicines receives new patent for Angiomax

10/8/09 | Theflyonthewall.com

Tuesday, October 6, 2009

Medicines sets 3Q revenue outlook below forecasts

10/6/09 | AP ONLINE

The Medicines Co. sees Q3 total net revenue $96M-$98M vs. consensus of $110M

10/6/09 | Theflyonthewall.com

Monday, October 5, 2009

SEC Filing: Current Event

10/5/09 View all News Related Articles > | Thomson Financial

Friday, October 2, 2009

Medicines Co. President, COO John Kelley resigns

10/2/09 View all News Related Articles > | AP ONLINE

The Medicines Company announces resignation of COO

10/2/09 | Theflyonthewall.com

Tuesday, September 29, 2009

The Medicines Co. licenses new formulation of Argatroban

9/29/09 | Theflyonthewall.com

Saturday, September 26, 2009

Boston Scientific Says Data From Horizons-AMI Trial Show Superior Efficacy - Update

9/26/09 | RTTNews

Friday, September 25, 2009

The Medicines Co. announces clinical results for HORIZONS-AMI trial

9/25/09 | Theflyonthewall.com

The Medicines Co. announces clinical trial results for

9/25/09 | Theflyonthewall.com

Boston Scientific: Study shows superior efficacy for Taxus Express stents

9/25/09 | Theflyonthewall.com

Deutsche Bank's healthcare analyst hosts a conference call

9/25/09 | Theflyonthewall.com

Wednesday, September 23, 2009

4 Stocks Losing Top Investor Support

9/23/09 | The Motley Fool

Thursday, September 10, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

9/10/09 | Thomson Financial

Wednesday, September 2, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

9/2/09 | StockHouse

Tuesday, September 1, 2009

SEC Filing: Insider Buy/Sell

9/1/09 View all News Related Articles > | Thomson Financial

Medicines Co.'s Angiomax Promising - Analyst Blog

9/1/09 | Zacks Investment Research

Monday, August 31, 2009

The Medicines Company Announces New Publication of Data Showing Angiomax(R) Reduces Cardiac Mortality and Improves Overall Survival

8/31/09 | StockHouse

Friday, August 21, 2009

Medicines Co. Withdraws MAA - Analyst Blog

8/21/09 | Zacks Investment Research

Monday, August 10, 2009

SEC Filing: Quarterly Financials

8/10/09 View all News Related Articles > | Thomson Financial

Wednesday, July 29, 2009

Medicines Q2 Profit Dips - Update

7/29/09 | RTTNews

Monday, July 27, 2009

SEC Filing: Current Event

7/27/09 View all News Related Articles > | Thomson Financial

Thursday, July 23, 2009

SEC Filing: Insider Buy/Sell

7/23/09 | Thomson Financial

The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor

7/23/09 | TradingMarkets

Thursday, July 16, 2009

BiomedReports: FDA and News Updates for MedLink (OTC: MLKNA), The Medicines Company (NASDAQ: MDCO), Nuvilex, Inc. (OTC:NVLX), and ALDA Pharmaceuticals Corp. (OTC:APCSF)

7/16/09 | TradingMarkets

Friday, June 19, 2009

Medicines Co. Wins Additional 6-month Exclusivity For Angiomax In Children - Update

6/19/09 View all News Related Articles > | RTTNews

Wednesday, June 10, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

6/10/09 | Thomson Financial

Wednesday, June 3, 2009

SEC Filing: Current Event

6/3/09 | Thomson Financial

Zacks Analyst Blog Highlights: JPMorgan Chase, American Express, Morgan Stanley, Bank of America and The Medicines Co.

6/3/09 View all News Related Articles > | TradingMarkets

Tuesday, June 2, 2009

Cautious on The Medicines Company - Analyst Blog

6/2/09 | Zacks Investment Research

1 <Next>
Friday, October 30, 2009

Zacks Sell List Highlights: The Great Atlantic & Pacific Tea Co., Encore Wire Corp., Pool Corp. and The Medicines Co. ..

10/30/09 | PR-inside - Austria

Wednesday, October 28, 2009

The Medicines Company Reports Third Quarter 2009 Financial Results Total Sales in Third Quarter Up 12%, Year to Date Up 19%, ..

10/28/09 View all Trade Related Articles > | PR-inside - Austria

Monday, October 26, 2009

The Medicines Company Announces Positive CHMP Opinion For Angiox(R) For Use In Heart Attack Patients Undergoing Emergency Heart Procedures

10/26/09 View all Trade Related Articles > | Medical News Today - UK

Friday, October 23, 2009

The Medicines Company Announces Positive CHMP Opinion for Angiox (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures

10/23/09 View all Trade Related Articles > | PharmaLive

Stock Hot Tips Alert on CCTR,CSRH NRG,J.D. POWER,The Medicines Company

10/23/09 | WallSt.net

Thursday, October 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

10/15/09 View all Trade Related Articles > | PharmaLive

Thursday, October 8, 2009

The Medicines Company Announces Second New Patent Issuance for Angiomax(R)

10/8/09 View all Trade Related Articles > | PR-inside - Austria

Tuesday, October 6, 2009

The Medicines Company Announces Preliminary Third Quarter 2009 Top Line Results

10/6/09 View all Trade Related Articles > | PR-inside - Austria

Friday, October 2, 2009

The Medicines Company Announces the Resignation of Its Chief Operating Officer

10/2/09 | PharmaLive

Wednesday, September 30, 2009

09/30 - The Medicines Company licenses ready-to-use formulation of ant ...

9/30/09 | Pharmacy Choice

Tuesday, September 29, 2009

The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise

9/29/09 | PR-inside - Austria

Monday, September 28, 2009

The Medicines Company Angiomax Reduced Cardiac Mortality By 41%; Reduced Overall Mortality By 25% In Severe Heart Attack Patients Following Angioplasty, Columbia-Presbyterian Medical Center Study

9/28/09 View all Trade Related Articles > | BioSpace

Wednesday, September 16, 2009

The Medicines Company to Participate in the UBS Global Life Sciences Conference

9/16/09 | PR-inside - Austria

Tuesday, September 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

9/15/09 View all Trade Related Articles > | PR-inside - Austria

Friday, September 4, 2009

The Medicines Company Receives Paragraph IV Notifications

9/4/09 View all Trade Related Articles > | PharmaLive

Thursday, September 3, 2009

The Medicines Company Wins US Patent For Angiomax

9/3/09 View all Trade Related Articles > | Pharmaceutical Business Review Online - UK

Monday, August 31, 2009

The Medicines Company Announces New Publication of Data Showing Angiomax(R) Reduces Cardiac Mortality and Improves

8/31/09 View all Trade Related Articles > | PR-inside - Austria

Sunday, August 23, 2009

The Medicines Company Withdraws European Marketing Application For 3-7 Day Daily Dose Oritavancin Therapy

8/23/09 View all Trade Related Articles > | Medical News Today - UK

Thursday, August 20, 2009

The Medicines Company Withdraws European Marketing Application for 3-7 Day Daily Dose Oritavancin Therapy

8/20/09 | StockWatch

Friday, August 14, 2009

The Medicines Company Announces Option Grants Under Nasdaq Marketplace Rule 5635

8/14/09 | PR-inside - Austria

Friday, July 31, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

7/31/09 View all Trade Related Articles > | StockWatch

Thursday, July 30, 2009

The Medicines Company Reports Second Quarter Financial Results

7/30/09 | Pharmaceutical Business Review Online - UK

Wednesday, July 29, 2009

The Medicines Company Reports Second Quarter 2009 Financial Results Achieves First Quarter of Net Sales in

7/29/09 View all Trade Related Articles > | PR-inside - Austria

Friday, July 24, 2009

The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor

7/24/09 | PharmaLive

Thursday, July 23, 2009

The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief

7/23/09 | PR-inside - Austria

Wednesday, July 15, 2009

The Medicines Company to Announce Second Quarter 2009 Financial Results on Wednesday, July 29, 2009

7/15/09 View all Trade Related Articles > | StockWatch

Tuesday, June 30, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

6/30/09 | PR-inside - Austria

Monday, June 22, 2009

FDA Grants the Medicines Company (MDCO) Pediatric Exclusivity for Angiomax(R)

6/22/09 | Biocompare

Friday, June 19, 2009

FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)

6/19/09 View all Trade Related Articles > | StockWatch

Tuesday, June 16, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

6/16/09 View all Trade Related Articles > | PR-inside - Austria

Monday, June 1, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 4350

6/1/09 | PR-inside - Austria

Friday, May 15, 2009

The Medicines Company to Participate in the Deutsche Bank Health Care Conference

5/15/09 View all Trade Related Articles > | StockWatch

Wednesday, May 13, 2009

The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor

5/13/09 View all Trade Related Articles > | PR-inside - Austria

The Medicines Company

5/13/09 | Hugin Online - UK

The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor

5/13/09 | Hugin Online - UK

Thursday, April 30, 2009

The Medicines Company Announces Option Grants Under Nasdaq Marketplace Rule 4350

4/30/09 View all Trade Related Articles > | StockWatch

Thursday, April 23, 2009

For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro

4/23/09 | The Pink Sheet Daily

Wednesday, April 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 4350

4/15/09 View all Trade Related Articles > | StockWatch

The Medicines Company EU Filing Accepted For Cleviprex(R) For The Treatment Of Acute Hypertension

4/15/09 View all Trade Related Articles > | MediLexicon

Thursday, April 2, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 4350

4/2/09 | StockWatch

1 <Next>
Wednesday, October 22, 2008

The Medicines Co. posts a narrower loss...

10/22/08 View all Regional Related Articles > | Trenton Times - Trenton NJ

1
Friday, October 30, 2009

Zacks Sell List Highlights: The Great Atlantic & Pacific Tea Co., Encore Wire Corp., Pool Corp. and The Medicines Co.

10/30/09 | Business Wire

Wednesday, October 28, 2009

The Medicines Company Reports Third Quarter 2009 Financial Results

10/28/09 | Marketwire

Friday, October 23, 2009

The Medicines Company Announces Positive CHMP Opinion for Angiox® (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures

10/23/09 | Business Wire

Thursday, October 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

10/15/09 | Marketwire

Thursday, October 8, 2009

The Medicines Company Announces Second New Patent Issuance for Angiomax(R)

10/8/09 | Marketwire

Tuesday, October 6, 2009

The Medicines Company Announces Preliminary Third Quarter 2009 Top Line Results

10/6/09 | Marketwire

Friday, October 2, 2009

The Medicines Company Announces the Resignation of Its Chief Operating Officer

10/2/09 | Marketwire

Wednesday, September 30, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

9/30/09 | Marketwire

Tuesday, September 29, 2009

The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity

9/29/09 | Marketwire

Friday, September 25, 2009

Angiomax Reduced Cardiac Mortality by 41%; Reduced Overall Mortality by 25% in Severe Heart Attack Patients Following Angioplasty

9/25/09 | Marketwire

Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years

9/25/09 | PR Newswire

Wednesday, September 16, 2009

The Medicines Company to Participate in the UBS Global Life Sciences Conference

9/16/09 | Marketwire

Tuesday, September 15, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

9/15/09 | Marketwire

Friday, September 4, 2009

The Medicines Company Receives Paragraph IV Notifications

9/4/09 | Marketwire

Wednesday, September 2, 2009

The Medicines Company Announces New Patent Issuance for Angiomax(R)

9/2/09 | Marketwire

Monday, August 31, 2009

The Medicines Company Announces New Publication of Data Showing Angiomax(R) Reduces Cardiac Mortality and Improves Overall Survival

8/31/09 | Marketwire

Thursday, August 20, 2009

The Medicines Company Withdraws European Marketing Application for 3-7 Day Daily Dose Oritavancin Therapy

8/20/09 | Marketwire

Friday, August 14, 2009

The Medicines Company Announces Option Grants Under Nasdaq Marketplace Rule 5635

8/14/09 | Marketwire

Monday, August 10, 2009

The Medicines Company Responds to Incorrect News Reports

8/10/09 | Marketwire

Friday, July 31, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

7/31/09 | Marketwire

Wednesday, July 29, 2009

The Medicines Company Reports Second Quarter 2009 Financial Results

7/29/09 | Marketwire

Thursday, July 23, 2009

The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor

7/23/09 | Marketwire

Wednesday, July 15, 2009

The Medicines Company to Announce Second Quarter 2009 Financial Results on Wednesday, July 29, 2009

7/15/09 | Marketwire

Tuesday, June 30, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

6/30/09 | Marketwire

Friday, June 19, 2009

FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)

6/19/09 | Marketwire

Tuesday, June 16, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635

6/16/09 | Marketwire

Wednesday, June 3, 2009

Zacks Analyst Blog Highlights: JPMorgan Chase, American Express, Morgan Stanley, Bank of America and The Medicines Co.

6/3/09 | Business Wire

Monday, June 1, 2009

The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 4350

6/1/09 | Marketwire

Friday, May 15, 2009

The Medicines Company to Participate in the Deutsche Bank Health Care Conference

5/15/09 | Marketwire

Thursday, May 14, 2009

Zacks Analyst Blog Highlights: Allegheny Energy, Inc., Vivus, Inc., Georgia Gulf Corporation, Sempra Energy and The Medicines Company

5/14/09 | Business Wire

Wednesday, May 13, 2009

Stock Alerts on Today's Headliners: VZ, M, MGM, CSCO, MON, MDCO; Issued by Beacon Equity

5/13/09 | PR Newswire

The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor

5/13/09 | Marketwire

Wednesday, May 6, 2009

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

5/6/09 | PR Newswire

Thursday, April 30, 2009

The Medicines Company Announce

Live Updates:

Ticker

Dynamic view of the market

MEDICINES CO

MDCO

Stock price

Extended Hours

MEDICINES CO Real-Time Headlines

Monday, November 09, 2009

Monday, November 2, 2009

Friday, October 30, 2009

Wednesday, October 28, 2009

Monday, October 26, 2009

Friday, October 23, 2009

Thursday, October 15, 2009

Friday, October 9, 2009

Thursday, October 8, 2009

Tuesday, October 6, 2009

Monday, October 5, 2009

Friday, October 2, 2009

Wednesday, September 30, 2009

Tuesday, September 29, 2009

Monday, September 28, 2009

Saturday, September 26, 2009

Friday, September 25, 2009

Monday, November 09, 2009

Monday, November 2, 2009

Wednesday, October 28, 2009

Friday, October 23, 2009

Friday, October 9, 2009

Thursday, October 8, 2009

Tuesday, October 6, 2009

Monday, October 5, 2009

Friday, October 2, 2009

Tuesday, September 29, 2009

Saturday, September 26, 2009

Friday, September 25, 2009

Wednesday, September 23, 2009

Thursday, September 10, 2009

Wednesday, September 2, 2009

Tuesday, September 1, 2009

Monday, August 31, 2009

Friday, August 21, 2009

Monday, August 10, 2009

Wednesday, July 29, 2009

Monday, July 27, 2009

Thursday, July 23, 2009

Thursday, July 16, 2009

Friday, June 19, 2009

Wednesday, June 10, 2009

Wednesday, June 3, 2009

Tuesday, June 2, 2009

Friday, October 30, 2009

Wednesday, October 28, 2009

Monday, October 26, 2009

Friday, October 23, 2009

Thursday, October 15, 2009

Thursday, October 8, 2009

Tuesday, October 6, 2009

Friday, October 2, 2009